Novavax previously announced it was awarded a gran
Post# of 317
(Total Views: 863)
Posted On: 07/25/2017 11:17:41 AM
Novavax previously announced it was awarded a grant of up to $89 million from the Bill & Melinda Gates Foundation to support development of this RSV F Vaccine, which includes Prepare, product licensing efforts and World Health Organization (“WHO”) prequalification of our RSV F Vaccine.
(0)
(0)Novavax Inc. (NVAX) Stock Research Links
Scroll down for more posts ▼